The first Wednesday Plenary Session at #AACR26 bring together experts advancing radioligand therapy, antibody-drug conjugates, T-cell engagers, and more. Get the full details in AACR Annual Meeting News: https://t.co/sHk1ej69K6 https://t.co/3Dd95KCISE